rexahn.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Ocuphire Pharma, Inc. |
| Description | Ocuphire Pharma is a clinical-stage ophthalmic biopharmaceutical company developing and commercializing therapies for the treatment of eye |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 174.129.30.187 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
rexahn.com Valuation
|
US$1,911
Last updated: 2023-05-13 08:31:13
rexahn.com has Semrush global rank of 0. rexahn.com has an estimated worth of US$ 1,911, based on its estimated Ads revenue. rexahn.com receives approximately 220 unique visitors each day. Its web server is located in United States, with IP address 174.129.30.187. According to SiteAdvisor, rexahn.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,911 |
| Daily Ads Revenue | US$1 |
| Monthly Ads Revenue | US$52 |
| Yearly Ads Revenue | US$635 |
| Daily Unique Visitors | 14 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| rexahn.com. | A | 3599 | IP: 174.129.30.187 |
| rexahn.com. | NS | 7200 | NS Record: ns46.worldnic.com. |
| rexahn.com. | NS | 7200 | NS Record: ns45.worldnic.com. |
| rexahn.com. | MX | 3600 | MX Record: 10 rexahn-com.mail.protection.outlook.com. |
| rexahn.com. | TXT | 3600 | TXT Record: MS=ms57628284 |
| rexahn.com. | TXT | 3600 | TXT Record: _globalsign-domain-verification=9Fzv94DkdE4yBEdRRo-lUAB3DftSAtQlLGuMXcteyz |
| rexahn.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-05-13 08:31:13
| Home About Overview Management Team Board of Directors Medical Advisory Board Product Pipeline Overview Nyxol APX3330 APX2009 Posters and Publications Clinical Trials Overview VEGA-2 Pivotal Phase 3 Trial of Nyxol® in Presbyopia Enrolling ZETA-1: Diabetic Retinopathy Phase 2 Clinical Trial for APX3330 Last Patient Last Visit Completed MIRA-4: Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis in Pediatric Subjects Completed MIRA-3 Completed MIRA-2: Reversal of Mydriasis Phase 3 Clinical Trial for Nyxol Completed LYNX-1: Dim Light Vision Disturbance Phase 3 Clinical Trial for Nyxol Completed VEGA-1: Presbyopia Phase 2 Clinical Trial for Nyxol with Low-Dose Pilocarpine Completed Partnerships News & Media Press Releases Presentations Events Ocuphire in the News Investors Overview News / Events Company Information Financial Information Stock Data SEC Filings Corporate Governance Contact Careers Restoring Vision and Clarity Ocuphire Pharma is a |
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Tue, 21 Dec 2021 01:41:24 GMT
Server: Apache
Location: https://www.ocuphire.com/
Content-Type: text/html; charset=UTF-8
HTTP/2 200
date: Tue, 21 Dec 2021 01:41:25 GMT
content-type: text/html; charset=UTF-8
expires: Thu, 19 Nov 1981 08:52:00 GMT
cache-control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
pragma: no-cache
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=ar9yQQ%2FnIjZY56ixEOi%2BQks2UNx%2FVxXynWSmigp%2Foqe8wr5fdx2Xe%2FEtmurTDMz2eeB7NIOnsvDnwWG0B%2F3ZrJWgwdKr%2BnWMMqIBv6GZndGNteNs6IUT1PfiqMf2NY4FBS%2B7"}],"group":"cf-nel","max_age":604800}
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
cf-ray: 6c0d686f6ca11875-EWR
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
|
rexahn.com Whois Information
Domain Name: REXAHN.COM Registry Domain ID: 52454307_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2019-01-21T10:31:44Z Creation Date: 2001-01-18T06:55:19Z Registry Expiry Date: 2024-01-18T06:55:19Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS45.WORLDNIC.COM Name Server: NS46.WORLDNIC.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-24T07:50:51Z <<< |